Incontinence
·MeSH: Nocturnal Enuresis
8 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 4(8)
| Drug | Company |
|---|---|
| 1% lidocaine with sodium bicarbonate | Revance Therapeutics, Inc. (RVNC) |
| Beta3-Agonists, Adrenergic [Mirabegron/Vibegron] | Revance Therapeutics, Inc. (RVNC) |
| Botox® injection | Revance Therapeutics, Inc. (RVNC) |
| Botulinum toxin A or physiologic serum injection | Revance Therapeutics, Inc. (RVNC) |
| onabotulinumtoxin A | Revance Therapeutics, Inc. (RVNC) |
| OnabotulinumtoxinA | Revance Therapeutics, Inc. (RVNC) |
| OnabotulinumtoxinA 100 UNT [Botox] | Revance Therapeutics, Inc. (RVNC) |
| Phenazopyridine | Revance Therapeutics, Inc. (RVNC) |
Compare drugs
Frequently asked questions
How many drugs are in development for Incontinence?
BioSniper tracks 8 drugs in development for Incontinence across 1 company.
How many clinical trials target Incontinence?
There are 1 clinical trial targeting Incontinence tracked by BioSniper.
Analyze Revance Therapeutics, Inc.'s Incontinence pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company